Table 3.
TNM Staging and K-M Analyses of GNET Patients
| Features | Group Classification | Statistical Results | K-M Analysis of OS (P-value) | K-M Analysis of DFS (P-value) |
|---|---|---|---|---|
| Histological grades | G2 | 88.1%(37/42) | 0.039 | 0.842 |
| G3 | 11.9%(5/42) | |||
| T (topography) | T1 | 22.0%(11/50) | 0.19 | 0.662 |
| T2a | 34.0%(17/50) | |||
| T2b | 34.0%(17/50) | |||
| T3 | 2.0%(1/50) | |||
| T4 | 8.0%(4/50) | |||
| N (lymph invaded) | N0 | 54.5%(31/57) | 0.027 | 0.146 |
| N1 | 45.6%(26/57) | |||
| M (distant metastasis) | M0 | 75.0%(42/56) | 0.603 | 0.447 |
| M1 | 25.0%(14/56) | |||
| M+N | Yes | 45.6%(26/57) | 0.026 | 0.030 |
| No | 54.4%(31/57) | |||
| Adjuvant therapy | Overall treatments | 71.7%(33/46) | 0.037 | / |
| Postoperative treatments | 47.8%(22/46) | 0.99 | 0.697 |
Note: Bold and italic values indicateP < 0.05.